Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infe (Q50639042)
Jump to navigation
Jump to search
scientific article published in March 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infe |
scientific article published in March 1999 |
Statements
Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infe (English)
1 reference
S E Krown
1 reference
D Aeppli
1 reference
H H Balfour
1 reference
1 March 1999
1 reference
20
1 reference
3
1 reference
245-254
1 reference